BlackRock Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BlackRock Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$251K	Hold	185,871	–	–	﹤0.01%	3202
2016 Q3	$290K	Sell	185,871 -704	-0.4%	-$1.08K	﹤0.01%	3189
2016 Q2	$248K	Buy	186,575 +10,595	+6%	+$49.5K	﹤0.01%	3257
2016 Q1	$927K	Buy	175,980 +1,888	+1%	+$11.6K	﹤0.01%	2535
2015 Q4	$1.37M	Buy	174,092 +1,335	+0.8%	+$11.5K	﹤0.01%	2355
2015 Q3	$1.46M	Sell	172,757 -1,218	-0.7%	-$11.2K	﹤0.01%	2306
2015 Q2	$1.91M	Buy	173,975 +32,201	+23%	+$413K	﹤0.01%	2277
2015 Q1	$1.98M	Buy	141,774 +1,643	+1%	+$25.1K	﹤0.01%	2034
2014 Q4	$2.37M	Sell	140,131 -722	-0.5%	-$10.5K	﹤0.01%	1904
2014 Q3	$1.89M	Buy	140,853 +62	+0%	+$738	﹤0.01%	2038
2014 Q2	$1.79M	Buy	140,791 +8,011	+6%	+$83.4K	﹤0.01%	2166
2014 Q1	$1.58M	Buy	132,780 +787	+0.6%	+$10.6K	﹤0.01%	2191
2013 Q4	$1.82M	Sell	131,993 -2,833	-2%	-$40K	﹤0.01%	2083
2013 Q3	$2.35M	Buy	134,826 +8,394	+7%	+$161K	﹤0.01%	1842
2013 Q2	$2.05M	Buy	+126,432	New	+$3.91M	﹤0.01%	1841

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Investment Management's INFI Position: Q4 2016 in Review

BlackRock Investment Management held its Infinity Pharmaceuticals, Inc. (INFI) position steady in Q4 2016 at 185,871 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #3202.

BlackRock Investment Management first reported a position in INFI in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.37M in Q4 2014. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

BlackRock Investment Management held 185,871 shares of Infinity Pharmaceuticals, Inc. worth $251K as of Q4 2016.
BlackRock Investment Management left its Infinity Pharmaceuticals, Inc. share count unchanged in Q4 2016.
Infinity Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3202 holding.
BlackRock Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $2.37M in Q4 2014.
94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.